JACOBS LEVY EQUITY MANAGEMENT, INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$3,463,994
+51.9%
209,939
-41.8%
0.02%
+61.5%
Q2 2023$2,280,629
+60.6%
360,859
-13.7%
0.01%
+44.4%
Q1 2023$1,419,955
-40.9%
418,249
+0.7%
0.01%
-43.8%
Q4 2022$2,400,637
+288.5%
415,335
+9496.5%
0.02%
+220.0%
Q4 2020$618,0004,3280.01%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders